Monitoring the spread of drug-resistant infections in hospitals
Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network
This study is trying to see how common drug-resistant infections are in a hospital by testing samples from patients and looking at their medical information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 12000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Luebeck Academic / other |
| Locations | 1 site (Lübeck) |
| Trial ID | NCT04937361 on ClinicalTrials.gov |
What this trial studies
This observational study aims to survey the prevalence of multidrug-resistant organisms (MDRO) within a university hospital network. It involves taking rectal swabs from inpatients to cultivate and analyze the presence of MDRO, as well as documenting community-onset and nosocomial bloodstream infections. Clinical data will be collected for each infection case, including patient demographics and antibiotic therapy details. Additionally, the study will explore the genetic mechanisms of resistance and the impact of COVID-19 infection control measures on these infections.
Who should consider this trial
Good fit: Ideal candidates for this study are inpatients aged 18 and older who can provide informed consent.
Not a fit: Patients who are under 18 years old or those who are outpatients will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of MDRO dynamics and improve infection control strategies in hospitals.
How similar studies have performed: Other studies have shown success in monitoring MDRO dynamics, making this approach both relevant and necessary in current healthcare settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 18 years old * informed consent * inpatient Exclusion Criteria: * less than 18 years old * Not capable of giving informed consent * outpatient
Where this trial is running
Lübeck
- Klinik für Infektiologie und Mikrobiologie — Lübeck, Germany (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.